Starten Sie Ihre Suche...


Durch die Nutzung unserer Webseite erklären Sie sich damit einverstanden, dass wir Cookies verwenden. Weitere Informationen

How durable is the effect of low intensity CBT for depression and anxiety? Remission and relapse in a longitudinal cohort study

BEHAVIOUR RESEARCH AND THERAPY. Bd. 94. 2017 S. 1 - 8

Erscheinungsjahr: 2017

Publikationstyp: Zeitschriftenaufsatz

Doi/URN: 10.1016/j.brat.2017.04.006

Volltext über DOI/URN

GeprüftBibliothek

Inhaltszusammenfassung


Background: Depression and anxiety disorders are relapse-prone conditions, even after successful treatment with pharmacotherapy or psychotherapy. Cognitive behavioural therapy (CBT) is known to prevent relapse, but there is little evidence of the durability of remission after low intensity forms of CBT (LiCBT). Method: This study aimed to examine relapse rates 12 months after completing routinely-delivered LiCBT. A cohort of 439 LiCBT completers with remission of symptoms provided monthly dep...Background: Depression and anxiety disorders are relapse-prone conditions, even after successful treatment with pharmacotherapy or psychotherapy. Cognitive behavioural therapy (CBT) is known to prevent relapse, but there is little evidence of the durability of remission after low intensity forms of CBT (LiCBT). Method: This study aimed to examine relapse rates 12 months after completing routinely-delivered LiCBT. A cohort of 439 LiCBT completers with remission of symptoms provided monthly depression (PHQ-9) and anxiety (GAD-7) measures during 12 months after treatment. Survival analysis was conducted to model time-to-relapse while controlling for patient characteristics. Results: Overall, 53% of cases relapsed within 1 year. Of these relapse events, the majority (79%) occurred within the first 6 months post-treatment. Cases reporting residual depression symptoms (PHQ-9 = 5 to 9) at the end of treatment had significantly higher risk of relapse (hazard ratio = 1.90, p < 0.001). Conclusions: The high rate of relapse after LiCBT highlights the need for relapse prevention, particularly for those with residual depression symptoms. (C) 2017 Elsevier Ltd. All rights reserved. » weiterlesen» einklappen

Autoren


Ali, Shehzad (Autor)
Rhodes, Laura (Autor)
Moreea, Omar (Autor)
McMillan, Dean (Autor)
Gilbody, Simon (Autor)
Leach, Chris (Autor)
Lucock, Mike (Autor)
Delgadillo, Jaime (Autor)

Verknüpfte Personen


Beteiligte Einrichtungen